Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
30 Aug 2026
Alcohol Biomarker Identified Potential MetALD in MASLD
PEth was elevated in 11% of patients screened for MASLD trials, suggesting alcohol use warranting evaluation for possible MetALD or ALD.
30 Aug 2026
New Assay Could Simplify HIV Drug Resistance Testing
An optimised reverse transcriptase assay detected very low HIV viral loads and phenotypic drug resistance in around 2 hours, potentially offering a more accessible approach to resistance monitoring.
30 Aug 2026
Knowledge Gaps Affected Liver Cancer Surveillance
HCC surveillance faced knowledge and access barriers, with only 15% of patients identifying liver cancer detection as its purpose.
29 Aug 2026
Imaging Reveals Widespread Silent Atherosclerosis Burden: ESC 2026
Findings from a large imaging study presented during ESC Congress 2026 suggested silent atherosclerosis present in more than half of adults without known cardiovascular disease.
29 Aug 2026
GLP-1 Medication Linked to Lowered Risk of TB in Type 2 Diabetes
GLP-1 receptor agonists were linked to a lower risk of tuberculosis in people with type 2 diabetes.
29 Aug 2026
CKD Screening Recommended in Heart Disease: ESC 2026
New ESC guidelines call for routine CKD screening in patients with CVD, aiming to improve early diagnosis, optimise treatment, and reduce cardiovascular and kidney complications.
29 Aug 2026
Leukocyte Telomere Length Shows Limited Value in Pancreatic Cancer
Leukocyte telomere length showed limited diagnostic and prognostic value in pancreatic ductal adenocarcinoma, while exploratory microbiome data found no significant group differences.
29 Aug 2026
Urine Tumour DNA Predicts Bladder Cancer Recurrence
Urine tumour DNA testing identified patients at increased recurrence risk following BCG treatment and detected some recurrences months before clinical diagnosis.
29 Aug 2026
Growth Factor Receptors Signal Schizophrenia Disease Stage
Researchers identified lower nGFR levels in early psychosis and elevated eGFR and ITGB1 across schizophrenia spectrum disorders.
29 Aug 2026
Placental Epigenetic Changes Link to Persistent Food Allergy
Placental DNA methylation changes, reduced IL-10, and elevated Th2 cytokines were associated with an early persistent food allergy trajectory.
←
1
2
3
…
26
27
28
29
30
31
32
…
1,605
1,606
1,607
→
We’ve noticed you’re accessing
from
North/South America.
View
View